Atlas Trials

18F-Fluciclovine PET to Distinguish Tumor Progression From Radiation Necrosis

Clinical trial NCT03930173 · COMPLETED

Trial details

NCT number
NCT03930173
Sponsor
Case Comprehensive Cancer Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Secondary Malignant Neoplasm of Brain and Cerebral Meninges
Start date
2019-07-02
Primary completion
2021-03-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.